Having produced more positive diagnostics results, Proteomics plans to launch its PromarkerEndo device locally this year
Proteomics International Laboratories (ASX:PIQ) has come up with more positive data to support its endometriosis diagnosis test PromarkerEndo, presented – aptly – to the World Congress on Endometriosis, held in Sydney over the weekend.
